233 related articles for article (PubMed ID: 27134017)
1. The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors.
Mazzaferro V; Sposito C; Coppa J; Miceli R; Bhoori S; Bongini M; Camerini T; Milione M; Regalia E; Spreafico C; Gangeri L; Buzzoni R; de Braud FG; De Feo T; Mariani L
Am J Transplant; 2016 Oct; 16(10):2892-2902. PubMed ID: 27134017
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
Rossi RE; Burroughs AK; Caplin ME
Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
Moris D; Tsilimigras DI; Ntanasis-Stathopoulos I; Beal EW; Felekouras E; Vernadakis S; Fung JJ; Pawlik TM
Surgery; 2017 Sep; 162(3):525-536. PubMed ID: 28624178
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for metastatic neuroendocrine tumors.
Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
[TBL] [Abstract][Full Text] [Related]
6. Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation.
Ruzzenente A; Bagante F; Bertuzzo F; Aldrighetti L; Campagnaro T; Ercolani G; Conci S; Giuliante F; Dore A; Ferrero A; Torzilli G; Grazi GL; Ratti F; Cucchetti A; De Rose AM; Russolillo N; Cimino M; Perri P; Guglielmi A; Iacono C
J Gastrointest Surg; 2019 Jan; 23(1):93-100. PubMed ID: 30242647
[TBL] [Abstract][Full Text] [Related]
7. Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients.
Dong XD; Carr BI
Med Oncol; 2011 Dec; 28 Suppl 1():S286-90. PubMed ID: 21107755
[TBL] [Abstract][Full Text] [Related]
8. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
[TBL] [Abstract][Full Text] [Related]
9. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons.
Sposito C; Droz Dit Busset M; Citterio D; Bongini M; Mazzaferro V
Rev Endocr Metab Disord; 2017 Dec; 18(4):473-483. PubMed ID: 29359266
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following liver transplantation for metastatic neuroendocrine tumors.
Grąt M; Remiszewski P; Smoter P; Wronka KM; Grąt K; Lewandowski Z; Koperski L; Górnicka B; Pacho R; Zborowska H; Patkowski W; Krawczyk M
Transplant Proc; 2014 Oct; 46(8):2766-9. PubMed ID: 25380913
[TBL] [Abstract][Full Text] [Related]
11. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
[TBL] [Abstract][Full Text] [Related]
12. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
13. The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors.
Citterio D; Coppa J; Sposito C; Busset MDD; Virdis M; Pezzoli I; Mazzaferro V
Curr Treat Options Oncol; 2023 Nov; 24(11):1651-1665. PubMed ID: 37882889
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial.
Dueland S; Smedman TM; Syversveen T; Grut H; Hagness M; Line PD
JAMA Surg; 2023 Sep; 158(9):e232932. PubMed ID: 37494056
[TBL] [Abstract][Full Text] [Related]
16. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
Rosenau J; Bahr MJ; von Wasielewski R; Mengel M; Schmidt HH; Nashan B; Lang H; Klempnauer J; Manns MP; Boeker KH
Transplantation; 2002 Feb; 73(3):386-94. PubMed ID: 11884935
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables.
Sher LS; Levi DM; Wecsler JS; Lo M; Petrovic LM; Groshen S; Ji L; Uso TD; Tector AJ; Hamilton AS; Marsh JW; Schwartz ME
J Surg Oncol; 2015 Aug; 112(2):125-32. PubMed ID: 26171686
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
Korda D; Doros A; Piros L; Gerlei Z; Haboub-Sandil A; Mándli T; Fazakas J; Deák ÁP; Máthé Z
Transplant Proc; 2019 May; 51(4):1251-1253. PubMed ID: 31101208
[TBL] [Abstract][Full Text] [Related]
19. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
20. Younger Age Is Associated with Improved Survival in Patients Undergoing Liver Transplantation Alone for Metastatic Neuroendocrine Tumors.
Valvi D; Mei X; Gupta M; Shah MB; Ancheta A; Marti F; Gedaly R
J Gastrointest Surg; 2021 Jun; 25(6):1487-1493. PubMed ID: 32632728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
